ASTH
Astrana Health, Inc.
Platform & Compounding FCF
C-
46.9 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
6.2%
-
Operating Margin Trend
-2.52 pp/yr
-
5yr Avg ROE
8.5%
-
5yr Share-Count CAGR
5.7%
-
5yr Revenue CAGR
53.8%
-
5yr EPS CAGR
-14.6%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
4.0%
-
5yr FCF/NI Conversion
1.68x
-
Net Debt / EBITDA
4.79x
-
Interest Coverage (EBIT/Int)
1.79x
-
Altman Z-Score
2.59
Stability
Weight: 5%
C-
50
-
EPS Volatility (σ/μ)
0.48
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
3
Not held by any curated guru.